Cancer treatment merits a deeper, relentless probe through a proper assessment of the immunological status and genomic aspects of each case. It calls for a multi-disciplinary approach aimed at providing the right treatment, the very first time. Any intervention based on hasty conclusions invariably leads to cancer recurrence, which often proves life-threatening, apart from the financial and psychological hardships patients and their family members have to undergo in the process.
